Search results
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 3 days agoIdeally, these updated vaccines will be available in the fall. The Vaccines and Related Biological...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 2 days ago19. The CDC has recommended that adults 65 and older and people who are immunocompromised get a...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 5 days agoCOVID vaccine, agency staff said in a briefing document released Monday. In the briefing document,...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 3 days agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 1 day agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain
MedPage Today· 3 days agoAn FDA advisory committee voted unanimously, 16-0, Wednesday to recommend that the COVID-19 vaccines...
Why Things Could Get Worse for Pfizer Stock Before They Get Better | The Motley Fool
The Motley Fool· 2 days agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (PFE 0.20%) stock was a hot buy...
FDA advisers urge targeting JN.1 strain for fall’s COVID vaccines
Marshall Independent· 2 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive ...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 3 days agoThe Stock Advisor service has more than quadrupled the return...Renauer has no position in any of...
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
InvestorPlace· 1 day agoVaccine maker Novavax (NASDAQ:NVAX) saw its shares jump 18% on June 5 and another 20% in pre-market...